County
Marin County Emergency Medical Services Agency
Marin County Emergency Medical Services Agency (CA) carries 22 drugs across 99 dose entries in its current published protocol, effective 2025-04-01.
Drugs and doses22
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1000 mg | IV/IO | not captured | standing | page 81 |
| Mild to moderate pain | adult | 500–1000 mg | PO | not captured | standing | pages 81, 142, 144, 146, 148, 150, 152, 154, 156, 158 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 81, 142, 144, 146, 148, 150, 152, 154, 156, 158 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 86, 94, 130, 144, 146, 148, 150, 152, 154, 156, 158 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 86, 94, 130, 144, 146, 148, 150, 152, 154, 156, 158 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 86, 120, 144, 146, 148, 150, 152, 154, 156, 158 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 86, 120, 144, 146, 148, 150, 152, 154, 156, 158 |
| Burns | adult | 5 mg | NEB | not captured | standing | pages 101, 131 |
| Burns | peds | 2.5 mg | NEB | not captured | standing | pages 101, 131 |
| Other | adult | 5 mg | NEB | not captured | standing | pages 118, 140, 144, 146, 148, 150, 152, 154, 156, 158 |
| Other | peds | 5 mg | NEB | not captured | standing | pages 118, 140, 144, 146, 148, 150, 152, 154, 156, 158 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 150 mg | IV/IO | not captured | standing | page 95 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 86, 90, 127, 144, 146, 148, 150, 152, 154, 156, 158 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 86, 90, 127, 144, 146, 148, 150, 152, 154, 156, 158 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 67, 86, 95 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 86, 92, 129, 144, 146, 148, 150, 152, 154, 156, 158 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 86, 92, 129, 144, 146, 148, 150, 152, 154, 156, 158 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | pages 86, 105, 134, 144, 146, 148, 150, 152, 154, 156, 158 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 86, 105, 134, 144, 146, 148, 150, 152, 154, 156, 158 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 g | IV/IO | not captured | standing | pages 86, 125 |
| Crush injury | peds | 1 g | IV/IO | not captured | standing | pages 86, 125 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | pages 86, 91 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | pages 86, 87, 108, 132, 135, 138, 139, 146, 148, 150, 152, 154, 156 |
| Hypoglycemia | peds | 2–5 mL/kg | IV/IO | not captured | standing | pages 86, 87, 108, 132, 135, 138, 139, 146, 148, 150, 152, 154, 156 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | pages 86, 87, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 86, 87, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | pages 86, 87, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 86, 87, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Other | adult | 50 mg | IV/IO | not captured | standing | pages 86, 87, 105, 144, 146, 148, 150, 152, 154, 156 |
| Other | adult | 50 mg | IV/IO/IM | not captured | standing | pages 86, 87, 106, 131, 137, 144, 146, 148, 150, 152, 154, 156 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | pages 86, 87, 105, 144, 146, 148, 150, 152, 154, 156 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 86, 87, 106, 131, 137, 144, 146, 148, 150, 152, 154, 156 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3 mg | IM | not captured | standing | pages 86, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Allergic reaction | peds | 0.01 mg/kg | IM | not captured | standing | pages 86, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 86, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 86, 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | pages 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 104, 133, 144, 146, 148, 150, 152, 154, 156 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 86, 92, 129, 144, 146, 148, 150, 152, 154, 156 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 86, 89, 90, 91, 127, 128, 144, 146, 148, 150, 152, 154, 156 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 86, 89, 90, 91, 127, 128, 144, 146, 148, 150, 152, 154, 156 |
| Hypotension / shock | adult | 1 mL | IV/IO | not captured | standing | pages 86, 92, 97, 103, 107 |
| Other | peds | 5 mg | NEB | not captured | standing | pages 118, 123, 144, 146, 148, 150, 152, 154, 156 |
| Stridor | peds | 5 mg | NEB | not captured | standing | pages 118, 123, 144, 146, 148, 150, 152, 154, 156 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IN | not captured | standing | pages 86, 87, 142, 147, 149, 151, 153, 155, 157, 159 |
| Mild to moderate pain | adult | 50–100 mcg | IM | not captured | standing | pages 86, 87, 142, 147, 149, 151, 153, 155, 157, 159 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IN | not captured | standing | pages 86, 87, 142, 147, 149, 151, 153, 155, 157, 159 |
| Mild to moderate pain | peds | 1 mcg/kg | IM | not captured | standing | pages 86, 87, 142, 147, 149, 151, 153, 155, 157, 159 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IM | not captured | standing | pages 87, 134, 145, 147, 149, 151, 153, 155, 157, 159 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 87, 108, 132, 135, 138, 139, 145, 147, 149, 151, 153, 155, 157, 159 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 86, 123 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | pages 87, 120, 144, 145, 147, 149, 151, 153, 155, 157, 159 |
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | pages 87, 120, 144, 145, 147, 149, 151, 153, 155, 157, 159 |
| Asthma / bronchospasm | peds | 500 mcg | NEB | not captured | standing | pages 87, 120, 144, 145, 147, 149, 151, 153, 155, 157, 159 |
| Asthma / bronchospasm | peds | 500 mcg | NEB | not captured | standing | pages 87, 120, 144, 145, 147, 149, 151, 153, 155, 157, 159 |
| COPD | adult | 500 mcg | NEB | not captured | standing | pages 87, 120, 144, 145, 147, 149, 151, 153, 155, 157, 159 |
| COPD | peds | 500 mcg | NEB | not captured | standing | pages 87, 120, 144, 145, 147, 149, 151, 153, 155, 157, 159 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20–40 mg | IO | not captured | standing | pages 176, 189 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | pages 176, 189 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 mg | IV/IO | not captured | standing | pages 82, 145, 153 |
| Other | adult | 2–4 mg | IM | not captured | standing | page 82 |
| Other | adult | 5 mg | IN | not captured | standing | page 82 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 82, 145, 153 |
| Mild to moderate pain | adult | 1 mg | IV/IO | not captured | standing | pages 81, 145, 153 |
| Mild to moderate pain | adult | 2–4 mg | IM | not captured | standing | pages 81, 145, 153 |
| Mild to moderate pain | adult | 5 mg | IN | not captured | standing | pages 81, 145, 153 |
| Mild to moderate pain | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 81, 145, 153 |
| Mild to moderate pain | peds | 0.2 mg/kg | IM | not captured | standing | pages 81, 145, 153 |
| Mild to moderate pain | peds | 0.2 mg/kg | IN | not captured | standing | pages 81, 145, 153 |
| Procedural sedation | adult | 1 mg | IV/IO | not captured | standing | pages 82, 145, 153 |
| Procedural sedation | adult | 2–4 mg | IM | not captured | standing | pages 82, 145, 153 |
| Procedural sedation | adult | 5 mg | IN | not captured | standing | pages 82, 145, 153 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 82, 145, 153 |
| Procedural sedation | peds | 0.2 mg/kg | IM | not captured | standing | pages 82, 145, 153 |
| Procedural sedation | peds | 0.2 mg/kg | IN | not captured | standing | pages 82, 145, 153 |
| Seizure | adult | 5 mg | IM | not captured | standing | pages 109, 138, 145, 153 |
| Seizure | adult | 5 mg | IN | not captured | standing | pages 109, 138, 145, 153 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 109, 138, 145, 153 |
| Seizure | peds | 0.2 mg/kg | IN | not captured | standing | pages 109, 138, 145, 153 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 145, 147, 149, 151, 153, 155, 157 |
| Mild to moderate pain | adult | 5 mg | IV/IO | not captured | standing | pages 81, 87, 145, 147, 149, 151, 153, 155, 157 |
| Mild to moderate pain | adult | 5–10 mg | IM | not captured | standing | pages 81, 87, 145, 147, 149, 151, 153, 155, 157 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 81, 87, 145, 147, 149, 151, 153, 155, 157 |
| Mild to moderate pain | peds | 0.1 mg/kg | IM | not captured | standing | pages 81, 87, 145, 147, 149, 151, 153, 155, 157 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–4 mg | IV/IO/IM | not captured | standing | pages 87, 108, 117, 139, 145, 147, 149, 151, 153, 155, 157 |
| Opioid overdose | adult | 2–4 mg | IN | not captured | standing | pages 87, 108, 117, 139, 145, 147, 149, 151, 153, 155, 157 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 87, 108, 117, 139, 145, 147, 149, 151, 153, 155, 157 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 87, 108, 117, 139, 145, 147, 149, 151, 153, 155, 157 |
Nerve Gas Auto-Injector
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1 dose | IM | not captured | standing | page 87 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 67, 87, 95, 121 |
| Eclampsia / pre-eclampsia | adult | 0.4 mg | SL | not captured | standing | page 116 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IO | not captured | standing | pages 87, 106, 137, 145, 149, 151, 153, 155, 157 |
| Nausea / vomiting | adult | 4 mg | IM | not captured | standing | pages 87, 106, 137 |
| Nausea / vomiting | peds | 2–4 mg | IV/IO | not captured | standing | pages 87, 106, 137, 145, 149, 151, 153, 155, 157 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 125 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 90, 91, 125 |
| Other | adult | 50 mEq | IV/IO | not captured | standing | pages 105, 134, 153, 155, 157 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 90, 91, 125 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 105, 134, 153, 155, 157 |